PRKCQ-AS1 and neoplasm: Compound NSC617570 blocks PRKCQ‐AS1 binding to MSI2, leading to BMX mRNA disassociation from MSI2 protein, BMX reduction, ERK dephosphorylation, neuroblastoma cell proliferation suppression in vitro and tumor growth inhibition in vivo.